Chugai Pharmaceutical Co.

Chugai Seiyaku Kabushiki - gaisha (. Jap.中外 制 薬 株式会社; engl Chugai Pharmaceutical Co., Ltd.. ) Is a 1925 based in Tokyo Japanese pharmaceutical company. It is in the Nikkei 225 listed under ISIN JP3519400000. The registered company is based in Kita, the actual Chūō.

Since 1998, the company is active in the German market in the fields of hematology and oncology. The most famous products are Epogin ( erythropoietin) and Granocyte (G -CSF), in 2010 the company took over the distribution of capecitabine (Xeloda ®). 2002 merged with Roche, Chugai and Nippon was the fifth largest pharmaceutical company in Japan.